Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Breast Neoplasms 2Wounds and Injuries 1Stroke 1Stomach Neoplasms 1Spinal Cord Injuries 1Rectal Neoplasms 1Pain, Postoperative 1Muscular Atrophy 1Muscle Spasticity 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Ganglion Cysts 1Esophageal Neoplasms 1Cluster Headache 1Carcinoma, Renal Cell 1Breast Diseases 1Brain Injuries 1

Interventions

Interviews as Topic 2citric acid, ispaghula husk, sodium bicarbonate drug combination 1Vi-siblin 1Surveys and Questionnaires 1Sorbitol 1Psyllium 1Leucine-tRNA Ligase 1Karaya Gum 1Exercise 1Dosage Forms 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Low Anterior Resection Syndrome × Botulinum Toxins, Type A × Clear all
NCT01589471 2018-02-12

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed
23 enrolled
Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡